GlassScriptPhysician profile
Benjamin L Harris
NPI 1386954014
$396.77
in general payments reported to CMS, 2019-2025
11 companies · $129 in 2025
The $129 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.75 · 2022: $102 · 2023: $91.88 · 2024: $54.90 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $85.01 | 2025 | Arista |
| Abbvie INC. | $54.50 | 2022 | |
| Hologic INC | $41.13 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.17 | 2023 | |
| Organon LLC | $30.20 | 2023 | Nexplanon |
| Daiichi Sankyo INC. | $27.67 | 2024 | Injectafer |
| Amgen INC. | $27.23 | 2024 | Prolia, Evenity |
| Avanos Medical | $24.94 | 2022 | |
| Sage Therapeutics, LLC | $24.69 | 2025 | Zurzuvae |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.51 | 2023 | Xifaxan |
| Exeltis, USA INC. | $19.72 | 2025 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.